Entries by Virginie Langlois

A major step for Clinical Trials

In France, the conduct of clinical trials requires a prior express favourable opinion of a Committee for the protection of the persons, in French Comité de protection des personnes (CPP). The competent CPPs have been designated randomly, by means of a draw since a law of 2012, implemented in November 2016. However, the random designation did […]

2019 EUFEMED conference – Registration is Now Open

Registration for the 2019 conference of the European Federation for Exploratory Medicines Development (EUFEMED) is now open! The event will be held from May 15 – 17, 2019 in Lyon, France. The conference once again has an exciting scientific programme: The Changing Landscape of Early Medicines Development: Be Prepared! The two-day meeting will include a mixture of […]

EUFEMED First Forum – 19 September 2018

On 19 September, EUFEMED organized a successful Forum discussion at the University of Leuven in Belgium. The audience was invited to directly interact with the panel of regulators, leading to fruitful discussions to identify and mitigate risks for first-in-human and early clinical trials. Thanks to the speakers for contributing to the great success of this […]